GLYCOPHOS
- Product NDC
- 65219-348
- Requested package NDC
- 65219-348-10
- 11-digit product format
- 652190348
- Labeler code
- 65219
- Product ID
- 65219-348_05761514-5960-44b8-8e1d-7f0a1ceeee2a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Sodium Glycerophosphate
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Fresenius Kabi USA, LLC
- Application
- NDA220381
- Marketing category
- NDA
- Marketing start
- 2026-07-29
- Substance
- SODIUM GLYCEROPHOSPHATE ANHYDROUS
- Active strength
- 216 mg/mL
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N220381-001 | GLYCOPHOS | SODIUM GLYCEROPHOSPHATE | 4.32GM/20ML (216MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2026-07-29 | |
| N220381-002 | GLYCOPHOS | SODIUM GLYCEROPHOSPHATE | 21.6GM/100ML (216MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2026-07-29 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N220381-001 | GLYCOPHOS | 4.32GM/20ML (216MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2026-07-29 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N220381-002 | GLYCOPHOS | 21.6GM/100ML (216MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2026-07-29 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | N220381-001 | GLYCOPHOS | 4.32GM/20ML (216MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2026-07-29 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N220381-002 | GLYCOPHOS | 21.6GM/100ML (216MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2026-07-29 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | N220381-001 | GLYCOPHOS | 4.32GM/20ML (216MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2026-07-29 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N220381-002 | GLYCOPHOS | 21.6GM/100ML (216MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2026-07-29 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N220381-001 | GLYCOPHOS | 4.32GM/20ML (216MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2026-07-29 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N220381-002 | GLYCOPHOS | 21.6GM/100ML (216MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2026-07-29 | caaa826d4ba7… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- GLYCOPHOS
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| SODIUM GLYCEROPHOSPHATE ANHYDROUS | 216 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| YP1H63LJ2K | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| e887e473-f1a7-40f1-bd6e-c99e7db7420d | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GLYCOPHOS | SODIUM GLYCEROPHOSPHATE | Fresenius Kabi USA, LLC | e887e473-f1a7-40f1-bd6e-c99e7db7420d | 2026-10-08 | Warnings, Adverse reactions | 220381 NDA220381 65219-348-10 65219-348 65219034810 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 65219-348-10 | 65219034810 | 20 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (65219-348-10) / 100 mL in 1 VIAL, PHARMACY BULK PACKAGE (65219-348-01) | 2026-07-29 | No | No | Current |